Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ImmunityBio, Inc. logo — Outsmart Your Disease™

ImmunityBio, Inc.

Outsmart Your Disease™

Founded 2014 United States San Diego, United States 656 employees Post Ipo Debt Total: $1.11B Health Care, Health and Wellness

General Information

Company Name ImmunityBio, Inc.
Founded Year 2014
Location United States San Diego, United States +7
Employees 656
Industries Health Care, Health and Wellness
Funding Stage Post Ipo Debt
Social

Get notified when ImmunityBio, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ImmunityBio, Inc.

ImmunityBio is a Health Care startup based in the United States, founded in 2014. The company aims to develop cell and immunotherapy products to strengthen patients' natural immune systems in the fight against cancer and infectious diseases, with the slogan "Outsmart Your Disease™." Led by Dr. Patrick Soon-Shiong, the company focuses on activating the innate immune system and building immunological memory. Their vision, as articulated by Dr. Soon-Shiong, is to conquer cancer by harnessing the human immune system's power and reprogramming it to treat the host, not just the disease. ImmunityBio's innovative approach has garnered attention and investment, with a recent $10.00M post-IPO equity investment on 02 January 2024 from Oberland Capital. The company's dedication to addressing unmet needs in oncology and infectious diseases, along with its visionary leadership, positions it as a promising player in the healthcare and biotechnology industry.

Taxonomy: Immunotherapy, Cancer, Infectious Diseases, Natural Killer, T Cell, Vaccines, Oncology, Fusion Proteins, Clinical Trials, Cell Therapy, COVID-19, Biopharmaceuticals, Biomedical Research, Medical Innovation

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1
Investor
02 Jan 2024
Post-IPO Equity •••••• 1
Investor
02 Jan 2024
Post-IPO Equity •••••• 1 •••• •••• 11 Sep 2023
Post-IPO Debt •••••• 1 •••• •••• 11 Sep 2023
Post-IPO Equity •••••• - 20 Jul 2023

View All 13 Funding Rounds

ImmunityBio, Inc. Alternatives & Competitors

ImmunityBio, Inc. vs
Taiga Biotechnologies
Taiga Biotechnologies United States

Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the power of t...

Seed
1 employees
Biotechnology, Health and Wellness
Compare ImmunityBio, Inc. vs Taiga Biotechnologies

FAQ About ImmunityBio, Inc.

Outsmart Your Disease™
ImmunityBio, Inc. was founded in 2014.
ImmunityBio, Inc. is headquartered in San Diego, United States.
ImmunityBio, Inc. operates in the following industries: Health Care, Health and Wellness.
ImmunityBio, Inc. has approximately 656 employees.
ImmunityBio, Inc. has completed 13 funding rounds, raising a total of $1.11B. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to ImmunityBio, Inc. include Taiga Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ImmunityBio, Inc. and Taiga Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ImmunityBio, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy